These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12789387)

  • 21. Comparison of a needle-free high-pressure injection system with needle-tipped injection of intracavernosal alprostadil for erectile dysfunction.
    Harding LM; Adeniyi A; Everson R; Barker S; Ralph DJ; Baranowski AP
    Int J Impot Res; 2002 Dec; 14(6):498-501. PubMed ID: 12494285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment.
    La Vignera S; Calogero AE; Cannizzaro MA; Condorelli R; Noto Z; Vicari E
    Minerva Endocrinol; 2006 Dec; 31(4):251-61. PubMed ID: 17213792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Erectile dysfunction: clinical course with intracavernous PGE1].
    Ruiz Rubio JL; Paez Borda A; Romero Cagigal R; Ruiz de Laroja JC; Sánchez Sánchez E; Fernández González I; Llorente Abarca C; Berenguer Sánchez A
    Arch Esp Urol; 1996 Apr; 49(3):253-6. PubMed ID: 8702346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does compression of the base of the penis improve the efficacy of intracavernosal injection of prostaglandin E1 for impotence? A randomized controlled study.
    el-Saleh JC; Keogh EJ; Chew KK; Earle CM; Lee JL; Wearmouth JW
    Int J Impot Res; 1995 Mar; 7(1):23-31. PubMed ID: 7670590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostaglandin E1--the pharmacologic prosthesis].
    de Boccard GA; Rochat CH
    Ann Urol (Paris); 1993; 27(3):152-5. PubMed ID: 8352576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice.
    Rajpurkar A; Dhabuwala CB
    J Urol; 2003 Jul; 170(1):159-63. PubMed ID: 12796670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The causes of patient dropout from penile self-injection therapy for impotence.
    Mulhall JP; Jahoda AE; Cairney M; Goldstein B; Leitzes R; Woods J; Payton T; Krane RJ; Goldstein I
    J Urol; 1999 Oct; 162(4):1291-4. PubMed ID: 10492182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections.
    Nandipati K; Raina R; Agarwal A; Zippe CD
    Int J Impot Res; 2006; 18(5):446-51. PubMed ID: 16482200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does prostaglandin E1 therapy modify the intracavernous musculature?
    Wespes E; Sattar AA; Noël JC; Schulman CC
    J Urol; 2000 Feb; 163(2):464-6. PubMed ID: 10647655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High attrition rate with intracavernous injection of prostaglandin E1 for impotency.
    Irwin MB; Kata EJ
    Urology; 1994 Jan; 43(1):84-7. PubMed ID: 8284888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracavernosal injection therapy. Does it still have a role in erectile dysfunction?
    Chew KK
    Aust Fam Physician; 2001 Jan; 30(1):43-6. PubMed ID: 11211711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of intraurethral alprostadil in patients not responding to sildenafil citrate.
    Jaffe JS; Antell MR; Greenstein M; Ginsberg PC; Mydlo JH; Harkaway RC
    Urology; 2004 May; 63(5):951-4. PubMed ID: 15134987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E1 as treatment for erectile failure in elderly men.
    Godschalk MF; Chen J; Katz PG; Mulligan T
    J Am Geriatr Soc; 1994 Dec; 42(12):1263-5. PubMed ID: 7983289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro viability of human cavernosal endothelial and fibroblastic cells after exposure to papaverine/phentolamine and prostaglandin E1.
    Pilatz A; Schultheiss D; Gabouev AI; Schlote N; Mertsching H; Jonas U; Stief CG
    BJU Int; 2005 Jun; 95(9):1351-7. PubMed ID: 15892829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment of Peyronie's disease based on penile length and degree of curvature.
    Bokarica P; Parazajder J; Mazuran B; Gilja I
    Int J Impot Res; 2005; 17(2):170-4. PubMed ID: 15215882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential penile ultrasound monitoring of patients treated with chronic intracavernous prostaglandin E1.
    Hirsch IH; Schanne FJ; Carsello J; Bagley DH; Alexander AA
    Urology; 1995 Jun; 45(6):1037-41. PubMed ID: 7771005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous temperature measurements in men with penile prostheses: a comparison study.
    Fogarty JD; Bleustein CB; Hafron JM; Melman A
    Int J Impot Res; 2005; 17(6):506-9. PubMed ID: 15889119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
    Briganti A; Fabbri F; Salonia A; Gallina A; Chun FK; Dehò F; Zanni G; Suardi N; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2007 Sep; 52(3):702-7. PubMed ID: 17418936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracavernosal injection therapy: a practical guide.
    Mulhall JP
    Tech Urol; 1997; 3(3):129-34. PubMed ID: 9422443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.